The results indicated that the expression of SLC39A8 in patients with distant metastasis or lymph node metastasis was significantly decreased, and the prognosis of those patients with decreased expression of SLC39A8 was significantly worse. The gene discussed is SLC39A8; the disease is metastatic malignant neoplasm in the lymph nodes.